University Hospital, Angers
chu-angers.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
469
Active
102
Phase 3
32
Total enrollment
504,221
Pipeline matrix
Showing 21 of 21 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| cyclosporine | — | — | — | — | 2 | ||
| Nicotinamide | — | — | — | — | — | 1 | |
| Idarubicin | — | — | — | — | — | 1 | |
| Daunorubicin | — | — | — | — | — | 1 | |
| HD Cytarabine | — | — | — | — | — | 1 | |
| Methotrexate | — | — | — | — | — | 1 | |
| Mycophenolic acid | — | — | — | — | — | 1 | |
| vosaroxin | — | — | — | — | — | 1 | |
| ID cytarabine | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Venetoclax | — | — | — | — | — | 1 | |
| Rivaroxaban 10 MG | — | — | — | — | — | 1 | |
| Low Heparin Molecular Weight | — | — | — | — | — | 1 | |
| Nicotinamide treatment | — | — | — | — | — | 1 | |
| Progressive (gradual) weaning of external ventricular drain | — | — | — | — | — | 1 | |
| Clonal architecture determination | — | — | — | — | — | 1 | |
| Continuous measurement of uPO2 | — | — | — | — | — | 1 | |
| Blood test | — | — | — | — | — | 1 | |
| Sulthiame | — | — | — | — | — | 1 | |
| Whole blood samples | — | — | — | — | — | 1 | |
| CALR allele burden quantification | — | — | — | — | — | 1 |
Next readouts
- 2025-07
- 2025-12-01
- 2026-07-09
- 2026-09
- 2027-04-23
- 2027-04-28
- 2027-09-01
- 2027-10-18
- 2028-04
- 2028-11-19
Top conditions
- Peripheral Artery Disease11
- Pseudoxanthoma Elasticum9
- Pulmonary Embolism8
- Peripheral Arterial Disease7
- Septic Shock7
- Healthy6
- Thoracic Outlet Syndrome6
- Acute Respiratory Distress Syndrome5
Frequently asked questions about University Hospital, Angers
- How many clinical trials does University Hospital, Angers have on ClinicalTrials.gov?
- University Hospital, Angers is listed as the lead sponsor on 469 clinical trials in ClinicalTrials.gov, 102 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital, Angers's trials are in Phase 3?
- 32 of University Hospital, Angers's trials are in Phase 3, spread across 21 active drug programs.
- What therapeutic areas does University Hospital, Angers focus on?
- University Hospital, Angers's most-studied conditions on ClinicalTrials.gov are Peripheral Artery Disease, Pseudoxanthoma Elasticum, Pulmonary Embolism, Peripheral Arterial Disease, Septic Shock.
- When are University Hospital, Angers's next clinical trial readouts?
- University Hospital, Angers has 10 upcoming primary-completion readouts tracked here; the soonest is “Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR”, expected around 2025-07.